EIT Health
Biotech Innovation Path Call
Last verified:
Details
| Funder | EIT Health |
| Budget | Up to €240,000 per project |
| Deadline | 16 September 2026 |
| Consortium | Required — minimum 2 HEIs from 2 different eligible EU Member States, plus at least 1 non-academic/industry partner; at least 1 HEI must be in an EIT RIS region |
| Application | Single stage; application platform opens 15 July 2026 |
| Frequency | One-off |
Eligibility & scope
Funds design and delivery of an EIT Label-certified Biotech pathway (personalised learning courses) within the Certified Innovation Path portfolio. Consortium must include ≥2 HEIs in ≥2 eligible Member States (at least one in an EIT RIS region) and ≥1 industry/non-academic partner. At least one HEI must be authorised to award ECTS credits. Focus on health biotech innovation, entrepreneurship, and translation to market-ready solutions across Europe.
More from EIT Health
Innovation Uptake Call
Deadline: 16 Sept 2026Up to €650k per project; total call budget up to €5.2MTransformative Healthcare Instrument
Deadline: 16 Sept 2026€300k–€500k (max 50% of total project costs)Entrepreneurship & Innovation Micro-Credentials Call
Deadline: 16 Sept 2026Up to €150k in 2027 + up to €60k in 2028Healthcare Regulations: Ensuring Regulatory Compliance by Design
€300 excl. VAT (course fee)Health Data Privacy: Aligning Innovation and Regulation through PETs (Privacy-Enhancing Technologies)
Browse Related
Could Biotech Innovation Path Call be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →